Archives

Sobrera Pharma AB Completes Oversubscribed Financing Round, Ahead of Key Development Milestones Gothenburg, Sweden – February 5, 2026 Sobrera Pharma AB today announced the successful completion [...]

The result of the phase 2 trial for patients with Alcohol Use Disorder (AUD) study has been published in The Lancet Regional Health – Europe. The result shows that two existing medications with [...]

March 7 2024 Our CEO Ann-Charlotte Rosendahl presented Sobrera Pharma at Life Science-dagen in Gothenburg. View the presentation below (in Swedish).

The phase II Proof of Concept (COMB study protocol has been published at PLOS ONE, an inclusive journal community for research in science and medicine. This is an important step in the [...]